Morning Market Losers By: Benzinga via Benzinga March 27, 2015 at 09:57 AM EDT Ohr Pharmaceutical, Inc. (NASDAQ: OHRP) shares dropped 65.64% to $3.00 on failure to reach goal in OHR-102 Phase II study. ... Read More >> Related Stocks: Applied Dna Scns Central Pacific Financial Company GameStop Corp Ohr Pharmceutial Reeds Inc